Table 3 Genotype and allele counts for NOD1/CARD4 variants in New Zealand IBD patients and in New Zealand Caucasians

105 (52.2)

255 (66.7)

1.29

(0.56–2.98)

226 (56.5)

0.61

(0.28–1.31)

481 (61.4)

0.84

(0.40–1.77)

87 (43.3)

111 (29.0)

0.68

(0.29–1.59)

142 (35.5)

0.46

(0.21–1.01)

253 (32.3)

0.53

(0.25–1.13)

9

(4.5)

17 (4.4)

1.00

32 (8.0)

1.00

49 (6.3)

1.00

0.002

0.08

0.01

0.10

0.28

0.15

0.05

105 (26.1)

145 (18.9)

206 (25.8)

351 (22.4)

297 (73.9)

621 (81.1)

594 (74.3)

1215 (77.6)

0.66 (0.49–0.89)

0.98 (0.74–1.30)

0.82 (0.63–1.06)

0.004

0.89

0.12

20 (10.0)

28

(7.3)

1.00

17

(4.2)

1.00

45

(5.7)

1.00

60 (30.0)

122 (31.9)

1.45

(0.76–2.79)

135 (33.6)

2.65

(1.29–5.41)

257 (32.8)

1.90

(1.05–3.46)

120 (60.0)

232 (60.7)

1.38

(0.75–2.55)

250 (62.2)

2.45

(1.23–4.85)

482 (61.5)

1.79

(1.02–3.14)

0.52

0.02

0.09

0.007

0.04

0.82

0.17

100 (25.0)

178 (23.3)

169 (21.0)

347 (22.1)

300 (75.0)

586 (76.7)

635 (79.0)

1221 (77.9)

0.91 (0.69–1.21)

0.80 (0.60–1.06)

0.85 (0.66–1.10)

0.52

0.12

0.22

21 (10.3)

31

(8.2)

1.00

20

(5.0)

1.00

51

(6.6)

1.00

73 (36.7)

129 (34.3)

1.20

(0.64–2.23)

161 (40.3)

2.32

(1.18–4.53)

290 (37.4)

1.64

(0.93–2.89)

105 (52.8)

216 (57.4)

1.39

(0.76–2.54)

219 (54.7)

2.19

(1.14–4.22)

435 (56.1)

1.71

(0.98–2.96)

0.48

0.04

0.16

0.12

0.07

0.16

0.78

115 (28.9)

191 (25.4)

201 (25.1)

392 (25.3)

283 (71.1)

561 (74.6)

599 (74.9)

1160 (74.7)

0.84 (0.64–1.10)

0.83 (0.63–1.08)

0.83 (0.65–1.06)

0.20

0.16

0.14